Pegloticase Use for Uncontrolled Gout in the Dialysis Population Described
New study is the first to characterize pegloticase use in the dialysis population.
Article Type: Distributed Content
Self-Administration Option Approved for Xolair Prefilled Syringe
Xolair, an anti-immunoglobulin E antibody, is indicated for the treatment of moderate to severe persistent asthma, chronic idiopathic urticaria, and nasal polyps.
Oral Glucokinase Activator Gets Breakthrough Tx Status for Type 1 Diabetes
TTP399 is an investigational oral, hepatoselective glucokinase activator.
CDC, FDA Recommend Pausing Use of Janssen COVID-19 Vaccine After Reports of Rare Blood Clot
In all 6 cases, symptoms developed 6 to 13 days after vaccination.
Pamrevlumab Fast Tracked for Duchenne Muscular Dystrophy
Pamrevlumab is a first-in-class fully human antibody that works by inhibiting the activity of connective tissue growth factor.
Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
Lucira Check It Test Kit Available OTC for At-Home COVID-19 Testing
The Lucira Check It COVID-19 test kit utilizes a molecular amplification technology to detect SARS-CoV-2 RNA.
Gemtesa Now Available for Overactive Bladder Treatment
Gemtesa is an oral, once-daily, small molecule beta-3 adrenergic agonist.
FDA Clears AI System to Detect Lesions During Colonoscopy
Results showed that the detection rate for adenomas or carcinomas was significantly higher with GI Genius compared with standard colonoscopy alone.
Xywav Gets Priority Review for Idiopathic Hypersomnia
The sNDA is supported by data from a phase 3 study that assessed Xywav in adults with idiopathic hypersomnia.
